FindTrial
Sign In

Pathological mechanisms and treatment strategy of branch atheromatous disease

Pathological mechanisms and treatment strategy of branch atheromatous disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064673
Enrollment
Unknown
Registered
2022-10-14
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

Case series:NA

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with branch atheromatous disease diagnosed according to the 2021 Chinese Expert Consensus on branch atheromatous disease.

Exclusion criteria

Exclusion criteria: 1. Patients who do not understand the problem or refuse to be enrolled.

Design outcomes

Primary

MeasureTime frame
National Institutes of Health Stroke Scale;Modified Rankin Scale;—

Countries

China

Contacts

Public ContactChenglin Tian

Chinese PLA General Hospital

tianchenglin719@aliyun.com+86 010-55499319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026